United States · FDA National Drug Code directory
TOPIRAMATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-374_4a2276a1-54f6-4de6-8710-c2c088a23e76
- Product NDC
- 68462-374
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- topiramate
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210201
- Source listing expiry
- 20271231
Source-listed ingredients
- TOPIRAMATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-374-05) · 68462-374-05
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-374-30) · 68462-374-30
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-374-90) · 68462-374-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →